| Source NDC Code |
|
Target HCPCS Code |
00574-0931-25
DOXORUBICIN LIPOSOME 50 MG/25 ML
|
⇄
|
Q2049
INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, IMPORTED LIPODOX, 10 MG
|
| Detail Information |
| Relationship Start Date |
10/25/2021 |
| Relationship End Date |
04/30/2024 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00574-0931-25
DOXORUBICIN HCL LIPOSOME (SDV,PF,LATEX-FREE) 2 MG/1 ML
|
⇄
|
Q2050
INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10 MG
|
| Detail Information |
| Relationship Start Date |
10/13/2021 |
| Relationship End Date |
04/30/2024 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|